Recent News

By Category: Biosafety

Experimental therapies: growing interest in the use of whole blood or plasma from recovered Ebola patients (convalescent therapies)

Ebola virus disease currently has no vaccines or medicines approved by national regulatory authorities for use in humans save for the purpose of compassionate care. To date, the virus has infected 6242 people and killed 2909 of them. These figures, which are far greater than those from all previous Ebola outbreaks combined, are known by  Read More »

White House Issues New Regulations for Dangerous Biological Research

NewYorkTimes: The Obama administration on Wednesday issued new guidelines intended to strengthen the oversight of federally funded biology research that could inadvertently produce bio-weapons. The new policy shifts the burden of finding and disclosing the dangerous aspects of research from the funding agency — usually the National Institutes of Health — to the scientists who  Read More »

Years of Preparation Pay Off with Ebola Diagnostic

Estimating the Future Number of Cases in the Ebola Epidemic — Liberia and Sierra Leone, 2014–2015

Center for Disease Control and Prevention: The CDC predicts that the Ebola virus outbreak could affect nearly one million people by January 2014 if containment measures are not immediately implemented.

Development of Self-Powered Chemical and Biological Sensors

GlobalBiodefense: New types of smart materials that can respond to selective stimuli hold promise in the development of novel platforms for self-powered chemical and biological (CB) sensors that can sense and destroy threat agents.